The Affiliated Hospital Of Southwest Medical University
Luzhou, Sichuan, 646000, China
NCT Number: NCT05257876
The study will follow the MRC Framework to develop an evidence-based BE intervention protocol to help breast cancer survivors with better management of cancer-related chronic pain.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Luzhou, Sichuan, 646000, China
Cancer-related chronic pain remains as a big challenge for cancer survivors, which significantly affects the quality of life of cancer survivors. Evidence suggests that pain is well managed through combination of pharmacological and non-pharmacological interventions. Among all non-pharmacological interventions, breathing exercise (BE) might have potential effect for chronic pain management in cancer survivors, but the evidence is sparse in current literature. Therefore, this study will follow the Medical Research Council Framework for Developing and Evaluating Complex intervention (the MRC Framework) to develop an evidence-based BE protocol to help with cancer-related chronic pain management in breast cancer survivors. The first two phases of the MRC Framework will be included in this study. In the first phase, an evidence-based method will be utilized to develop the BE intervention protocol. In the second phase, a pilot randomised controlled trial (RCT) will be conducted to examine the feasibility of study and the acceptability of the BE intervention by the participants as well as to preliminarily assess the effect of the BE on chronic pain management in breast cancer survivors. Semi-structured interviews will be conducted after the RCT to explore participants' experiences of participating in the study and practicing the BE.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive breathing exercise training, and a 4-week self exercise
Time frame: Immediately after the allocation of the last subject
The time that was taken to recruit the planned sample size of participants
Time frame: Immediately after the referral of the last subject
The number of referrals made by clinicians in different departments divided by all referrals
Time frame: Immediately after the recruitment of the last subject
Proportion of subjects who participated in the study from all subjects eligible for participation
Time frame: At the follow-up assessment 4 weeks after the intervention completion (T3)
Proportion of participants who completed the whole study divided by all subjects who enrolled in the study
Time frame: At the follow-up assessment 4 weeks after the intervention completion (T3)
The number of subjects who dropped out after randomization divided by all subjects who enrolled in the study
Time frame: Immediately once a dropout occurs
Feedback from the dropout subjects to identify their reasons for dropping out
Time frame: At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)
The percentage of missing values for each item of the scales used, including the Brief Pain Inventory (BPI), Quality of life Cancer Survivors Version (QOL-CSV), Functional Assessment Cancer Therapy-Breast (FACT-B), and Hospital Anxiety and Depression Scale (HADS)
Time frame: Immediately after completion of the 4-week intervention (T2)
the percentage of BE sessions performed by participants divided by the total number of BE sessions required
Time frame: Immediately after completion of the 4-week intervention (T2)
Participants' feedback on and satisfaction with the intervention using a specifically designed feedback form
Time frame: Immediately once an adverse event occurs
Data will be collected from the participants' BE logbooks and supplemented by information collected during weekly telephone contact
Time frame: At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)
Chronic pain will be measured by using the Brief Pain Inventory which measures pain intensity and pain interference with the life. For pain severity, four items are used to measure the "worst", "least", "average" and "now" with a rating scale from 0 to 10, higher number indicating the higher score in each item. For pain interference, pain is measured from 7 aspects of general activity, mood, walking, work, relations with others, sleep and enjoyment of life with a scale of 0-10, and higher score indicates severe impact of pain.
Time frame: At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)
Quality of life will be measured by using the Quality of Life Cancer Survivors Version. This questionnaire contains 41 items measuring quality of life of cancer survivors from four aspects including physical well-being, psychological well-being, social well-being and spiritual well-being. The score of each item is based on a scale of 0 ( worse outcome) to 10 ( best outcome). Higher score indicates better quality of life.
Time frame: At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)
Quality of life will also be measured by using the Functional Assessment of Cancer Therapy-Breast. This questionnaire has 37 items with a 5-point Likert scale ranging from 0 to 4, a higher score indicating better QoL.
Time frame: At baseline (T1), immediately after the completion of the 4-week intervention (T2), and the follow-up assessment at 4 weeks after the intervention completion (T3)
Anxiety and depression will be measured by using the Hospital Anxiety and Depression Scale (HADS). This scale contains 14 items consisting of two subscales: the anxiety subscale and depression subscale with 7 items in each. The scale uses a 4-point Likert scale ranging from 0 to 3, and higher score indicates severe anxiety and depression.
Charles Darwin University
Other
An Evidence-based Breathing Exercise Intervention Protocol for Chronic Pain Management in Breast Cancer Survivors: A Preliminary Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01089933
Agnosia, Breast Cancer
Ottawa, Ontario, Canada
View Trial DetailsNCT04586751
Anesthesia, Breast Cancer
Limassol, Cyprus
View Trial DetailsNCT04531917
Breast Diseases, Breast Neoplasms
Jette, Brussels Capital, Belgium
View Trial DetailsNCT05494502
Breast Diseases, Breast Neoplasms
Beijing, Beijing Municipality, China
View Trial Details